Drug
Tolbutamide clinical trials
- studies test it
- 8
- open now
- 0
- in phase 3
- 0
- first study started
- 2009
How studies write it
Studies that test it under each name
Name
Other names
Studies by the year they started
8 studies that test it; most in 2009 (2)
| Year | Studies |
|---|---|
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 8
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 0
Boehringer Ingelheim (2) · Pfizer (1) · Cognition Therapeutics (1) · Corcept Therapeutics (1) · Swedish Orphan Biovitrum (1) · AstraZeneca (1) · Eli Lilly and Company (1)
Often tested with
Tested in the same studies.
Midazolam (4) · Omeprazole (2) · Metoprolol (2) · Faldaprevir (2) · Caffeine (2) · Deleobuvir (2) · PF-06651600 (1) · Zervimesine (1)
Studies
Open first, then newest update. How each study uses Tolbutamide is read from its arms, and is right about nine times in ten.
Testing it · 8
- Study to Evaluate the Effect of Multiple-Dose Ritlecitinib on the Pharmacokinetics (PK) of TolbutamideCompletedPhase 1PfizerNCT05097716Written as Tolbutamide
- Drug Interaction Study of CT1812 in Healthy VolunteersCompletedPhase 1Cognition TherapeuticsNCT03716427Written as tolbutamide
- A Drug Interaction Study of Tasisulam in Patients With Advanced Cancer or LymphomaTerminatedPhase 1Eli Lilly and CompanyNCT01185548Written as Tolbutamide
- Study in Healthy Subjects to Determine the Effect of Relacorilant on Exposure to Probe Substrates for Cytochrome P450sCompletedPhase 1Corcept TherapeuticsNCT03457597Written as Tolbutamide
- A Study to Investigate the Potential Influence of Nitisinone on the Metabolism and the Transport of Other Drugs in Healthy VolunteersCompletedPhase 1Swedish Orphan BiovitrumNCT03103568Written as Tolbutamide
- Drug Drug Interaction Study Between BI 201335 and BI 207127 in Chronic Hepatitis C Infected PatientsCompletedPhase 1Boehringer IngelheimNCT01525628Written as tolbutamide
- Multiple Doses of BI 207127 NA, BI 201335 NA Followed by the Combination of BI 207127 NA and BI 201335 NA in Healthy Male VolunteersTerminatedPhase 1Boehringer IngelheimNCT02182401Written as Tolbutamide
- AZD2066 Cocktail StudyCompletedPhase 1AstraZenecaNCT00930306Written as Tolbutamide
Given in every arm · 6 — Tolbutamide is usual care beside what is tested
- Licorice Botanical Dietary Supplements - Metabolism and Safety in WomenCompletedPhase 1University of Illinois at ChicagoNCT03948243Written as Tolbutamide 250 mg
- Effect of Pexidartinib on the Way the Body Processes CYP3A4 and CYP2C9 Substrates (Pharmacokinetics)CompletedPhase 1Daiichi SankyoNCT03291288Written as Tolbutamide
- A Drug-Drug Interaction Study in Healthy Volunteers of the Effects of TucatinibCompletedPhase 1Seagen Inc.NCT03723395Written as tolbutamide
- A Study to Assess Effect of JNJ-54861911 on Pharmacokinetics of Cocktail Representatives for Cytochrome P450 (CYP) 3A4, CYP2B6, CYP2C9, and CYP1A2 SubstratesCompletedPhase 1Janssen Research & Development, LLCNCT02211079Written as Tolbutamide
- A PHASE 1, OPEN-LABEL, CROSS-OVER, FIXED SEQUENCE STUDY TO EVALUATE THE EFFECT OF MULTIPLE DOSES OF DS-1971A ON THE SINGLE DOSE PHARMACOKINETICS OF PROBE SUBSTRATES FOR CYP2B6, CYP2C8, CYP2C9, CYP2C19 AND CYP3A4 ENZYMES IN HEALTHY MALE AND FEMALE SUBJECTSCompletedPhase 1Daiichi SankyoNCT02473627Written as Tolbutamide
- Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced Solid TumorsCompletedPhase 1National Cancer Institute (NCI)NCT01218620Written as Tolbutamide
Codes
What other systems call Tolbutamide · ClinicalTrials.gg INT008333
- MeSH (NLM) D014044TolbutamideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 982XCM1FOITOLBUTAMIDEConfirmed FDA, NLM, Wikidata
- RxNorm 10635Confirmed FDA, Wikidata
- Wikidata Q414275tolbutamideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C66610TolbutamideOne source FDA
- DrugBank DB01124One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D014044 | Tolbutamide | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 982XCM1FOI | TOLBUTAMIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 10635 | — | Confirmed FDA, Wikidata |
| Wikidata | Q414275 | tolbutamide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C66610 | Tolbutamide | One source FDA |
| DrugBank | DB01124 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.